FR2845993B1 - PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES - Google Patents
PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USESInfo
- Publication number
- FR2845993B1 FR2845993B1 FR0212886A FR0212886A FR2845993B1 FR 2845993 B1 FR2845993 B1 FR 2845993B1 FR 0212886 A FR0212886 A FR 0212886A FR 0212886 A FR0212886 A FR 0212886A FR 2845993 B1 FR2845993 B1 FR 2845993B1
- Authority
- FR
- France
- Prior art keywords
- pde5
- compositions containing
- smooth muscle
- therapeutic uses
- containing same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 101100189582 Dictyostelium discoideum pdeD gene Proteins 0.000 title 1
- 101150098694 PDE5A gene Proteins 0.000 title 1
- 102100029175 cGMP-specific 3',5'-cyclic phosphodiesterase Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 210000002460 smooth muscle Anatomy 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0212886A FR2845993B1 (en) | 2002-10-16 | 2002-10-16 | PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES |
PCT/FR2003/003017 WO2004035584A1 (en) | 2002-10-16 | 2003-10-13 | Pharmaceutical compounds specifically inhibiting smooth muscle pde5, pharmaceutical compositions containing same and therapeutic uses thereof |
AU2003288318A AU2003288318A1 (en) | 2002-10-16 | 2003-10-13 | Pharmaceutical compounds specifically inhibiting smooth muscle pde5, pharmaceutical compositions containing same and therapeutic uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0212886A FR2845993B1 (en) | 2002-10-16 | 2002-10-16 | PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2845993A1 FR2845993A1 (en) | 2004-04-23 |
FR2845993B1 true FR2845993B1 (en) | 2005-02-11 |
Family
ID=32050450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0212886A Expired - Fee Related FR2845993B1 (en) | 2002-10-16 | 2002-10-16 | PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003288318A1 (en) |
FR (1) | FR2845993B1 (en) |
WO (1) | WO2004035584A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112021014566A2 (en) | 2019-01-24 | 2022-01-04 | Prometheus Biosciences Inc | gpr35 modulators |
TW202219047A (en) * | 2020-07-23 | 2022-05-16 | 美商普羅米修斯生物科學股份有限公司 | Therapeutic agents targeting gpr35 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103737A (en) * | 1997-07-03 | 2000-08-15 | Dupont Pharmaceuticals Company | Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists |
AU3621097A (en) * | 1997-07-09 | 1999-02-08 | Wolf-Georg Forssmann | Use of phosphordiesterase inhibitors in the treatment of prostatic diseases |
DE19838705A1 (en) * | 1998-08-26 | 2000-03-02 | Bayer Ag | New dihydro- (1,2,3) -triazolo- [4,5-d] pyrimidin-7-ones |
-
2002
- 2002-10-16 FR FR0212886A patent/FR2845993B1/en not_active Expired - Fee Related
-
2003
- 2003-10-13 WO PCT/FR2003/003017 patent/WO2004035584A1/en not_active Application Discontinuation
- 2003-10-13 AU AU2003288318A patent/AU2003288318A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003288318A1 (en) | 2004-05-04 |
WO2004035584A1 (en) | 2004-04-29 |
AU2003288318A8 (en) | 2004-05-04 |
FR2845993A1 (en) | 2004-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1615623A4 (en) | Abuse-resistant oral dosage forms and method of use thereof | |
ATE464049T1 (en) | PHARMACEUTICAL COMBINATIONS OF HYDROCODONE AND NALTREXONE | |
IS7552A (en) | Benzotrelated heteroaryl amide derivatives of thienopyridine useful as therapeutic agents, pharmaceutical compositions containing them and methods of their use | |
EA200501586A1 (en) | PHARMACEUTICAL PRODUCTS | |
CY2013043I1 (en) | 4-OXOQUINOLINE COMPOUNDS AND THEIR USE AS INHIBITORS OF HIV INTEGRATION | |
EP1483277A4 (en) | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof | |
NO20062504L (en) | Compositions and dosage forms for improved absorption | |
FI7846U1 (en) | Pharmaceutical preparation containing oxycodone and naloxone | |
EP1660043A4 (en) | Immediate-release formulation of acid-labile pharmaceutical compositions | |
SI1562556T1 (en) | Pharmaceutical compositions and dosage forms of thalidomide | |
AU2003215245A8 (en) | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof | |
IL164022A0 (en) | Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same | |
HUP0300917A2 (en) | Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and pharmaceutical compositions containing them | |
IL162937A0 (en) | Pravastatin pharmaceutical formulations and methods of their use | |
ZA200500203B (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
DE60137069D1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING MODAFINE COMPOUNDS | |
WO2006059194A3 (en) | Pharmaceutical sustained-release composition containing clozapine | |
IL163959A (en) | Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them | |
EP1849468A3 (en) | Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist | |
FR2845993B1 (en) | PHARMACEUTICAL COMPOUNDS INHIBITORS SPECIFIC OF SMOOTH MUSCLE PDE5, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND THERAPEUTIC USES | |
FR2846327B1 (en) | N-BENZODIOXOLYL, N-BENZODIOXANYL AND N-BENZODIOXEPINYL ARYLCARBOXAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF DYSLIPIDEMIA AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
IS6437A (en) | New substituted pyrazolo [4,3-e] diazepine pharmaceutical compositions containing them, use as therapeutic products and methods of their manufacture | |
AU2003256157A1 (en) | Oral dosage forms of water insoluble drugs and methods of making the same | |
AU2003295713A8 (en) | Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions | |
ATE413171T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ASCORBIC ACID FOR THE TREATMENT OF FUNGAL SUPERINFECTIONS AND FUNGAL RECUPS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20060630 |